Skip to main content
NCBI home page
The World Journal of Men's Health logoLink to The World Journal of Men's Health
. 2022 Jan 25;40(4):551–560. doi: 10.5534/wjmh.210119

Novel DNAH1 Mutation Loci Lead to Multiple Morphological Abnormalities of the Sperm Flagella and Literature Review

Bao-Jun Zhuang 1, Su-Yun Xu 2, Liang Dong 3, Pei-Hai Zhang 1, Bao-Lin Zhuang 4, Xiao-Peng Huang 1, Guang-Sen Li 1, Yao-Dong You 1, Di'Ang Chen 1, Xu-Jun Yu 3,5,✉, De-Gui Chang 1,✉
PMCID: PMC9482856  PMID: 35118838

Abstract

The protein encoded by dynein axonemal heavy chain 1 (DNAH1) is a part of dynein, which regulates the function of cilia and sperm flagella. The mutant of DNAH1 causes the deletion of inner dynein arm 3 in the flagellum, leading to multiple morphological abnormalities of the sperm flagella (MMAF) and severe asthenozoospermia. However, instead of asthenozoospermia and MMAF, the result caused by the mutation of DNAH1 remains unknown. Here we report a male infertility patient with severe asthenozoospermia and teratozoospermia. We found two heterozygous mutations in DNAH1 (c.6912C>A and c.7076G>T) and which were reported to be associated with MMAF for the first time. We next collected and analyzed 65 cases of DNAH1 mutation and found that the proportion of short flagella is the largest, while the bent flagella account for the smallest, and the incidence of head deformity is not high in the sperm of these patients. Finally, we also analyzed 31 DNAH1 mutation patients who were treated with intracytoplasmic sperm injection (ICSI) and achieved beneficial outcomes. We hope our research will be helpful in the diagnosis and treatment of male infertility caused by DNAH1 mutation.

Keywords: Dyneins, Genes, Male infertility, Sperm tail

INTRODUCTION

Male infertility is a multifactorial pathological condition that affects approximately 7% of the male population [1]. Among all the factors leading to male infertility, genetic factors account for at least 15% of these patients [1]. In recent years, an increasing number of genes have been confirmed to be associated with male infertility [1]. However, due to the lack of evidence and clinical reports, the role of some of these genes is still not fully understood. Therefore, we report a clinical case of male infertility treated with multiple medications and two intracytoplasmic sperm injection (ICSI) for 8 years. During this period, this patient’s sperm quality was declined, and did not achieve pregnancy. Genetic testing determined two mutation loci in the dynein axonemal heavy chain 1 (DNAH1) loci in the patient. Previous studies showed that DNAH1 is related to multiple morphological abnormalities of the sperm flagella (MMAF) and results in male infertility [2,3,4]. Therefore, we collected and analyzed 65 cases of DNAH1 mutations causing infertility from 6 search engines. Our results might provide new strategies for the diagnosis and treatment of male infertility caused by DNAH1 mutations.

MATERIALS AND METHODS

1. Case report

This is a case for a 43-year-old male who suffered from infertility for eight years. Several consecutive semen analyses showed that the patients had severe asthenozoospermia, moderate/severe oligozoospermia, teratozoospermia. His chromosome presented 46XY, the development of secondary sexual characteristics was normal, and he had no family history of genetic diseases (both brothers had given birth naturally). This patient was diagnosed without symptoms related to primary ciliary dyskinesia (PCD), such as chronic lung disease, chronic sinusitis and hearing impairment. He received several drugs during the treatment, such as Vitamin E Soft Capsules (Zhejiang Medicine Co., Ltd., Shaoxing, Zhejiang, China), Coenzyme Q10 Capsules (Eisai China Inc. Shanghai, China), Zinc Gluconate (Aonuo [China] Pharmaceutical Co., Ltd, Baoding, Heibei, China), Aescuven Forte (Cesra Arzneimittel GmbH& Co.KG, Baden, Germany), Levocarnitine Oral Solution (Northeast Pharmaceutical Group Shenyang No.1 Pharmaceutical Co., Ltd., Shenyang, Liaoning, China) for at least five years. However, his sperm quality did not improve, and the sperm concentration tended to decrease (Fig. 1). The abnormal semen results of the patient were shown in Supplement File 1, Extension 1, 2 (examination standards according to the WHO laboratory manual for the examination and processing of human semen-5th ed [5]). Subsequently, we observed rare motile sperm extracted by testicular sperm extraction (TESE) in January 2017 (Supplement File 1, Extension 3).

Fig. 1. Changes in sperm concentration in the patient.

Fig. 1

Open in a new tab

Other routine tests showed no significant abnormalities. Ultrasonic examination (Supplement File 1, Extension 4), immunological tests (serum anti-sperm antibody, semen leukocytes, tray agglutination test, sperm immobilization test), sex hormone tests (Supplement File 1, Extension 5), and microbiological analyses (ureaplasma urealyticum, chlamydia trachomatis, herpes virus) related to infertility were not abnormal.

The patient underwent the ICSI twice in 2016 and 2017 separately for a total of 3 ICSI cycles, and both failed to conceive due to embryonic dysplasia (Supplement File 1, Extension 6, 7). The patient’s wife was a 32-years-old (2016) female, G0P0, with regular menstruation (28 days cycle, lasting 7 days, medium volume). She had no obvious medical conditions that affected her fertility.

The genetic test report (GRCH37/hg19) showed that the patient had two base mutations (c.6912C>A and c.7076G>T) in the DNAH1 (MIM No.603332) on chromosome 3, according to the American College of Medical Genetics and Genomics (ACMG) [6] (Supplement File 1, Extension 8). DNAH1 is the pathogenic gene for PCD 37 (OMIM: 617577)/Spermatogenic Failure 18 (OMIM: 617576). The disease is an autosomal recessive disease. However, since the patient’s father had died, it was impossible to determine whether the two mutation sites were on the allele.

This patient also had a KISS1R heterozygous mutation (c.875G>A), an autosomal recessive gene associated with central precocious/hypogonadotropic hypogonadism with an ACMG marker of “unsure significance”. This patient did not show symptoms associated with the KISS1R mutation.

To increase our understanding of DNAH1, we reviewed and searched the relevant literature, and our search strategy and results are reported below.

2. Search strategy and inclusion/exclusion criteria

The subject term (“DNAH1” OR “dynein, axonemal, heavy chain 1, human”) on PubMed, Web of Science, Embase, ScienceDirect, FMRS, and CNKI was searched and collected all the cases of DNAH1 mutations causing male infertility.

Case exclusion criteria: (1) Single patient’s semen test results were not listed; (2) Single DNAH1 mutation site with no indication of whether it is pure or heterozygous; (3) Cases with homozygote or compound heterozygote mutations in other genes affect semen quality; (4) Inclusion criteria in the literature include filtering for sperm concentration and vitality.

3. Ethics statement

The ethics committee of our hospital considers that this study is only a statistical collection of medical record information and does not involve actual specimens, so ethics committee approval is not required. We have obtained informed consent from the patients.

RESULTS

The search strategy yielded 204 studies. Of these, 23 papers (123 cases, combined with the case report above) contained cases of male infertility due to DNAH1 mutations (Supplement File 2) [2,3,4,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26], involving 89 mutant loci (the highest mutation frequency of c.11726_11727del). Sixty-five cases were obtained after screening by case exclusion criteria (Table 1). All included cases presented with male infertility, with no other PCD-related symptoms.

Table 1. Sperm concentration and vitality status of currently reported DNAH1 deficiency patients.

Author (reference) Sperm concentration 106/mL Vitality %
Sha et al (2017) [2], (2019) [7] 12.64±4.79 (n=12) 1.48±2.64 (n=12)
Wang et al (2017) [3], Wang (2017) [8] 19.03±7.59 (n=4) 61.38±8.23 (n=4)
Yang et al (2018) [4] 11.21±14.34 (n=2) None
Ben Khelifa et al (2014) [9], Wambergue et al (2016) [10] 26.23±17.45 (n=6) 43.67±19.86 (n=3)
Amiri-Yekta et al (2016) [11] 25.33±8.82 (n=6) 79.33±16.22 (n=6)
Yu et al (2021) [12] 12.67±14.97 (n=12) None
Jiang et al (2021) [13] 1.8 (n=1) 1 (n=1)
Hu et al (2021) [14] 16.33 (n=1) None
Zaman (2020) [15] 10±8.89 (n=3) None
Zhu (2019) [16] 16.08±7.47 (n=2) None
Yang (2016) [17] 10.94±5.36 (n=10) 32±7.21 (n=3)
Zhi (2019) [18] 34.75±5 (n=4) None
Oud et al (2021) [19] 20 (n=1) None
Current study 8.44 (n=1) None
Total 16.64±11.86 (n=65) 33.36±33.74 (n=29)
Open in a new tab

Values are presented as mean±standard deviation or mean only.

n: number of cases.

Some cases had multiple semen examination results or a range. The average of the maximum and minimum of the range or multiple results were included. A case of sperm concentration of “<1” was calculated as 1. Data that cannot be calculated are excluded (statistics with SPSS 26.0; IBM Corp., Armonk, NY, USA).

1. Sperm concentration and vitality statistics

Statistically, 34 patients suffer from oligozoospermia (sperm concentration <15×106/mL), accounting for 52.31% (total=65) (Fig. 2A); 20 patients were diagnosed necrozoospermia (vitality<58%), accounting for 68.97%, of which vitality=0% accounted for 24.1% (total=29) (Fig. 2B).

Fig. 2. (A) Percentage of different sperm concentrations. (B) Percentage of discrepancy vitality. (C) Sperm flagella defect xlink:type statistics.

Fig. 2

Open in a new tab

2. Sperm morphology statistics

Morphological analysis showed that the proportion of short flagella is the highest (53.45%±19.94%, multiple comparisons, p<0.01), the proportion of bent flagella is small (5.45%±3.3%, multiple comparisons, p<0.05) (Fig. 2C). Short flagella exceeded 40% in 78.95% of patients and only one case (3.13%) had bent flagella exceeding 10%. Both short flagella >40% and bent flagella <10% were present in 71.88% (n=32) of patients. Only a few sperm showed head abnormalities (9.91%±9.31%, n=18) and multiple morphological abnormalities (8.17%±4.57%, n=13).

3. Effectiveness of ICSI in the treatment of infertility caused by DNAH1 mutations

30 patients with infertility caused by DNAH1 mutations treated with ICSI were reported. Wambergue et al [10] performed ICSI for 6 couples with DNAH1 defects and all obtained embryos, 4 of which delivered successfully. The total fertilization, pregnancy and delivery rates showed no statistical difference with patients without the mutation [10]. Yu et al [12] performed ICSI on 4 patients with DNAH1 mutations and their partners, and all of them successfully obtained embryos. Two couples performed embryo transfer, 1 delivered successfully, and the other suffered an early miscarriage [12]. Sha et al [7] sperformed ICSI on 12 DNAH1 patients, 8 of them were clinically pregnant and 1 had a miscarriage. Wu et al performed ICSI on 8 patients, and the clinical pregnancy rate (% per embryo transfer) was 53.8% (7/13) [25,26]. Combined with the cases in the case report above, the embryonic implantation and clinical pregnancy rates were 30.26% (23/76) and 61.90% (13/21), respectively (Supplement File 3).

DISCUSSION

1. DNAH1 mutations cause severe asthenozoospermia and MMAF

The patient mentioned in the case report may have severe asthenozoospermia caused by abnormal sperm flagella structure caused by DNAH1 mutation.

Cilia/flagella protrude from the surface of almost all eukaryotic cells and have many various roles in human physiology [27]. In humans, ciliary motility is responsible for diverse biological processes, including symmetry breaking during embryogenesis, the circulation of cerebrospinal fluid in the brain, mucociliary clearance in innate defense, and the swimming of spermatozoa [28]. Cilia and sperm flagella have a common origin and share the common structural element, the internal cytoskeletal structure called axoneme, which is highly conserved throughout evolution. The axoneme contains 9 microtubules doublets (MTDs), 2 central pairs (CPs) (“9+2” pattern), some axoneme dynein, radial spoke (RS), nexin-dynein regulatory complex, and many other components that drive and regulate the movement of cilia or flagella (Fig. 3) [29].

Fig. 3. Schematic diagram of the ultrastructure of the sperm flagella. (A) Sperm. (B) Internal cross-section of sperm flagella. (C) Dynein and its related structures. The dark blue, light blue, and red parts are IDA1, IDA2, and IDA3, respectively, in a 3-3-2 arrangement. The red text in (B) is IDA, including IDA1, 2 and 3, and the red text in (C) is IDA3, which is the expression site of DNAH1. The green, brown, grey, and yellow parts are ODA, RS, MTDS or CP, and N-DRC, respectively. The defect of DNAH1 results in a deletion of IDA3, which becomes a 3-2-1 structure and leads to the loss of CP. Dynein and its related structures repeat every 96 nm. IDA: inner dynein arm, ODA: outer dyneim arm, RS: radial spoke, MTDs: microtubular doublets, CP: central pair, N-DRC: nexin-dynein regulatory complex, DNAH1: dynein axonemal heavy chain 1.

Fig. 3

Open in a new tab

Dynein is one of the three families of the cytoskeletal motor protein. They have been shown to drive intracellular transport towards the minus ends of microtubules and convert the chemical energy in adenosine triphosphate (ATP) into mechanical energy for movement [30,31]. The motion of dynein is generated by a conserved motor structural domain which contains a ring-shaped head with six AAA structural domains [32]. Dynein includes cytoplasmic dynein and axonemal dynein. Among them, axonemal dynein is connected to MTDs within the cilia, and it provides power for the beating of motile cilia [30,33]. Dynein is a microtubule-related motor protein complex composed of several heavy chains (HCs), light chains, and intermediate chains. HC is a massive protein of 4,500 residues [33], surround dynein as force-producing subunits [34]. The HC has ATP hydrolysis and ATP-sensitive microtubule-binding sites and is responsible for converting chemical energy into directed mechanical forces exerted on the microtubule surface [35]. Axonemal dynein is divided into outer dynein arm (ODA) and inner dynein arm (IDA). The ODA repeats every 24 nm [36], and seven different IDAs are repeated within the 96 nm range [37,38]. ODAs are responsible for providing acceleration power, and IDAs are involved in bending motion [29,39].

DNAH1 has 80 exons and is expressed in tissues such as the testis [40,41]. Seven IDAs are repeated in 96 nm with three different xlink:types (IDA1, IDA2, and IDA3) arranged in 3-2-2 groups (Fig. 3C). DNAH1 is a component of IDA3. DNAH1 mutations can cause the missing one head of the IDA3, leading to a 3-2-1 globular head arrangement [9,41]. ODA is not affected by DNAH1 deletion [11]. The absence of DNAH1 removes the anchoring site of the RS 3, which results in a disorganized microstructure with missing CP, resulting in a 9-0 structure [9].

The structural defect of axoneme dynein is the leading cause of PCD [42,43] and male infertility [44,45]. PCD, a rare autosomal recessive genetic disease with an incidence between 1/10000 and 1/15000 [46,47,48], is characterized by extensive genetic heterogeneity and clinical variabilities, such as chronic lung disease (bronchiectasis), chronic sinusitis, hearing impairment, situs inversus in 50% patients, and infertility [46]. The triad of bronchiectasis, chronic sinusitis, and situs inversus are called Kartagener syndrome, a subgroup of PCD [49]. PCD patients’ sperm is usually immobile with various ultrastructural defects of the sperm flagella, such as absences of the dynein arms, microtubular translocations, and RSs [50]. PCD patients often lack ODAs or IDAs in the sperm flagella and cilia. Compared to the loss of individual IDAs, the loss of ODAs results in more severe ciliary motility defects [28]. Studies showed that Chlamydomonas mutants lacking some IDAs have almost regular beating frequency, but the amplitude of flagellar beating has changed [39]. At present, the correlation between IDAs and PCD still needs to be testified by more researches [51]. Over 40 genes, including DNAH5, DNAH11, DNAI1, were demonstrated to be associated with PCD, and more genes continue to be discovered [46]. Although there is a view that DNAH1 may be the causative gene of PCD, there is still a lack of sufficient evidence [52,53,54].

Although DNAH1 is expressed in both sperm flagella and cilia, there are some differences between flagella and cilia [50]. Clinically, it was shown that most patients with DNAH1 mutations might only exhibit symptoms of infertility and no other PCD-related symptoms. Ben Khelifa et al [9] called this disease MMAF. MMAF may be a phenotypic variation of the classical forms of PCD [50]. Patients present with primary infertility characterized by a mosaic of flagellar abnormalities, including absent, short, coiled, bent, and irregular flagella [9].

Mouse dynamin heavy chain 7 (MDHC7) is the mouse orthologue to the human gene, DNAH1. MDHC7-/- mice exhibit deletion of the ATP binding site (P1-loop domain) of IDA [41]. Disruption of the MDHC7 gene result in asthenozoospermia and reduce cilia beating frequency without severe defects in the axonemal structure [55]. MDHC7-/- mice have severely lower sperm velocities than wild-type mice, with velocities not exceeding 100 µm/s. The sperms that were utterly unable to make forward progress were up to 99% or more, and these severely weakened sperm exhibited rapid (~15 Hz) low-amplitude vibrations of the midpiece region [56]. MDHC7-deficient sperm were entirely unable to penetrate media of elevated viscosity (25–4,000 cP) and could not enter the oviduct from the uterus [52]. However, a small minority (generally ~1%) could swim progressively, and their flagellar activity was impaired but not severely [56]. Both female and male MDHC7+/- mice were normal and fertile, and fertility in MDHC7-/- females were not affected. Furthermore, there was no increase in embryonic or postnatal lethality in MDHC7-/- and MDHC7+/- [55]. All 30 MDHC7-/- male mice in Neesen et al’s study did not obtain offspring [55]. However, the clinical significance of DNAH1 mutations in humans is unclear due to the scarcity of patients and the lack of rigorous controlled clinical trials.

2. Association of DNAH1 mutations with sperm concentration and vitality

About 15% of couples did not achieve pregnancy within 1 year. Male infertility-related factors, often accompanied by abnormal semen parameters, were found in half of the involuntary childless couples [57,58]. There are no authoritative statistics on the prevalence of oligozoospermia and necrozoospermia in the population, but it can be expected that both should be below 15%, which is an enormous disparity from 52.31% and 68.97%. None of the cases were filtered for sperm concentration and vitality in the selected literature, and it is reasonable to suspect that DNAH1 mutations may be significantly associated with the development of oligozoospermia and necrozoospermia. However, this conclusion is not rigorous and partially conflicts with the current mouse study. In MDHC7-/- mice, there were 62% of completely immobile sperm, but no significant sperm reduction was shown [55]. Unfortunately, we did not find second DNAH1-related literature involving sperm concentration.

At present, most reports on DNAH1 are cross-sectional studies. This patient is the first reported treatment of infertility caused by a DNAH1 mutation for up to eight years. Patients had persistent decreases in sperm concentration over the past five years and had poor TESE results. However, more evidence on whether the sperm concentration will change with age is needed.

3. Morphological characteristics of sperm with DNAH1 mutation

We found that spermatozoa from patients with DNAH1 mutations exhibited distinctive features: a high percentage of short flagella, a low percentage of bent flagella and head malformations, which contribute to the initial clinical screening. Clinically, we may consider the possibility of DNAH1 mutation in patients presenting a higher percentage of short flagella (>30%) and a lower rate of bent flagella (<10%).

4. Patients with DNAH1 compound heterozygous mutations have the possibility of natural pregnancy

In Sha et al’s study [2], we found that a person (P12’s father) with heterozygous mutations at two DNAH1 loci (c.5766-2A>G and c.10630G>T) may have successfully reproduced naturally. P12 has shorter or coiled sperm tails and very low or almost absent DNAH1 expression compared with healthy people. So P12 should be a compound heterozygous mutation patient with two mutant loci from each of his parents (Fig. 4). P12 and his parents have two identical DNAH1 heterozygous mutations. Therefore, the father of P12 should also be a DNAH1 compound heterozygous mutation patient. P12 was born before 1987 (the article was published in 2017 and the paper shows P12 as 30 years old), while the first in vitro fertilization in China was performed in 1988 [59] and the world’s first ICSI procedure was performed in 1992 [60]. So, the parents of P12 must have conceived naturally. Therefore, we can conclude that there is a possibility that patients with DNAH1 compound heterozygous mutations could have a natural pregnancy. We speculate that there may be two possibilities: (1) Individuals with DNAH1 mutations may show intermediate asthenozoospermia and low levels of morphological anomalies [9]; (2) Patients with DNAH1 mutations will have very few swimming sperm [55,56], which also has a chance to lead pregnancy.

Fig. 4. The two DNAH1 mutation loci in patient P12 are only likely to be on alleles. (A) When the two mutant loci c.5766-2A>G and c.10630G>T are on two alleles, P12 will exhibit symptoms of MMAF and both mutations are heterozygous. (B) When the two mutant loci c.5766-2A>G and c.10630G>T are on one chromosome, although both mutations are heterozygous, P12 will not exhibit symptoms of MMAF. (C, D) When one or both of the two mutant loci c.5766-2A>G and c.10630G>T are on both alleles, P12 will exhibit symptoms of MMAF, but one or both of these two mutations will be homozygous mutations rather than two heterozygous mutations. So P12 can only be the case of A, the compound heterozygous mutation. Similarly, the father of P12 could only be a compound heterozygous mutation. MMAF: multiple morphological abnormalities of the sperm flagella.

Fig. 4

Open in a new tab

5. ICSI can be used to treat infertility due to DNAH1 mutations, but it is unclear whether DNAH1 mutations will have an impact on ICSI treatment success

The outcome of ICSI in the treatment of MMAF has not yet been determined [61,62,63]. A total of 30 patients with infertility caused by DNAH1 mutations were reported to be treated with ICSI with good results. However, due to the small number of cases, more evidence is still needed for support. In in vitro experiments in mice, MDHC7-/- sperm could fertilize, but a reduced number of 8-cell stage embryos were obtained [55]. Whether patients with DNAH1 mutations have a lower success rate of ICSI treatment remains to be further confirmed.

CONCLUSIONS

The c.6912C>A and c.7076G>T mutations in DNAH1 may lead to asthenozoospermia and MMAF. We cannot draw any definite conclusions from the available data, but the possibility that DNAH1 might affect spermatogenesis and survival cannot be fully excluded. Patients with DNAH1 mutations have a high percentage of short flagella and less frequently have significantly elevated bent flagella. ICSI is effective in treating DNAH1 mutations, but it is unclear whether DNAH1 mutations affect the success rate of ICSI. Patients with DNAH1 compound heterozygous mutations might have the possibility of natural pregnancy.

Footnotes

Conflict of Interest: The authors have nothing to disclose.

Funding: This research was supported by Department of Science and Technology of Sichuan Province (Award Number: 2019YJ0327, Grant Recipient: Xu-Jun Yu); National Natural Science Foundation of China, General Program (Award Number: 81973647, Grant Recipient: Xu-Jun Yu); Xinglin Scholar Research Premotion Project of Chengdu University of TCM, Department Special Project (Award Number: 2020yky06, Grant Recipient: Xu-Jun Yu); Department of Science and Technology of Sichuan Province (Award Number: 2020YFS0373, Grant Recipient: De-Gui Chang).

Author Contribution:
  • Conceptualization: BJZ, YDY, XJY.
  • Data curation: BJZ, SYX, LD, BLZ, DAC.
  • Formal analysis: BJZ, XPH.
  • Funding acquisition: XJY.
  • Methodology: BJZ, SYX, XJY, PHZ.
  • Project administration: XJY.
  • Resources: XJY.
  • Supervision: XJY.
  • Validation: GSL, XJY, DGC.
  • Visualization: BJZ, SYX.
  • Writing – original draft: BJZ, SYX, LD, BLZ, XPH, GSL, YDY, DAC.
  • Writing – review & editing: PHZ, XJY, DGC.

Supplementary Materials

Supplementary materials can be found via https://doi.org/10.5534/wjmh.210119.

Supplement File 1
wjmh-40-551-s001.pdf (132.3KB, pdf)
Supplement File 2
wjmh-40-551-s002.xls (27.9KB, xls)
Supplement File 3
wjmh-40-551-s003.xls (11.3KB, xls)

References

  • 1.Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15:369–384. doi: 10.1038/s41585-018-0003-3. [DOI] [PubMed] [Google Scholar]
  • 2.Sha Y, Yang X, Mei L, Ji Z, Wang X, Ding L, et al. DNAH1 gene mutations and their potential association with dysplasia of the sperm fibrous sheath and infertility in the Han Chinese population. Fertil Steril. 2017;107:1312–1318.e2. doi: 10.1016/j.fertnstert.2017.04.007. [DOI] [PubMed] [Google Scholar]
  • 3.Wang X, Jin H, Han F, Cui Y, Chen J, Yang C, et al. Homozygous DNAH1 frameshift mutation causes multiple morphological anomalies of the sperm flagella in Chinese. Clin Genet. 2017;91:313–321. doi: 10.1111/cge.12857. [DOI] [PubMed] [Google Scholar]
  • 4.Yang X, Zhu D, Zhang H, Jiang Y, Hu X, Geng D, et al. Associations between DNAH1 gene polymorphisms and male infertility: a retrospective study. Medicine (Baltimore) 2018;97:e13493. doi: 10.1097/MD.0000000000013493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World Health Organization (WHO) WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: WHO; 2010. pp. 7–114. [Google Scholar]
  • 6.Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sha YW, Wang X, Su ZY, Mei LB, Ji ZY, Bao H, et al. Patients with multiple morphological abnormalities of the sperm flagella harbouring CFAP44 or CFAP43 mutations have a good pregnancy outcome following intracytoplasmic sperm injection. Andrologia. 2019;51:e13151. doi: 10.1111/and.13151. [DOI] [PubMed] [Google Scholar]
  • 8.Wang X. [Pathogenic genes identification of multiple morphological anomalies of the sperm flagella in human] [thesis] Jinan: Shandong University; 2017. Chinese. [Google Scholar]
  • 9.Ben Khelifa M, Coutton C, Zouari R, Karaouzène T, Rendu J, Bidart M, et al. Mutations in DNAH1, which encodes an inner arm heavy chain dynein, lead to male infertility from multiple morphological abnormalities of the sperm flagella. Am J Hum Genet. 2014;94:95–104. doi: 10.1016/j.ajhg.2013.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wambergue C, Zouari R, Fourati Ben Mustapha S, Martinez G, Devillard F, Hennebicq S, et al. Patients with multiple morphological abnormalities of the sperm flagella due to DNAH1 mutations have a good prognosis following intracytoplasmic sperm injection. Hum Reprod. 2016;31:1164–1172. doi: 10.1093/humrep/dew083. [DOI] [PubMed] [Google Scholar]
  • 11.Amiri-Yekta A, Coutton C, Kherraf ZE, Karaouzène T, Le Tanno P, Sanati MH, et al. Whole-exome sequencing of familial cases of multiple morphological abnormalities of the sperm flagella (MMAF) reveals new DNAH1 mutations. Hum Reprod. 2016;31:2872–2880. doi: 10.1093/humrep/dew262. [DOI] [PubMed] [Google Scholar]
  • 12.Yu W, An M, Xu Y, Gao Q, Lu M, Li Y, et al. Mutational landscape of DNAH1 in Chinese patients with multiple morphological abnormalities of the sperm flagella: cohort study and literature review. J Assist Reprod Genet. 2021;38:2031–2038. doi: 10.1007/s10815-021-02201-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Jiang C, Zhang X, Zhang H, Guo J, Zhang C, Li J, et al. Novel bi-allelic mutations in DNAH1 cause multiple morphological abnormalities of the sperm flagella resulting in male infertility. Transl Androl Urol. 2021;10:1656–1664. doi: 10.21037/tau-20-1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hu HY, Wei TY, Feng ZK, Li SJ, Zhao R, Yi XL, et al. Novel biallelic DNAH1 variations cause multiple morphological abnormalities of the sperm flagella. DNA Cell Biol. 2021;40:833–840. doi: 10.1089/dna.2021.0097. [DOI] [PubMed] [Google Scholar]
  • 15.Zaman Q. [A novel DNAH1 mutation and a novel reciprocal translocation t(9;22) underlying human male infertility, and deficiency of exonuclease 5 is dispensable for male fertility in mice] [thesis] Hefei: University of Science and Technology of China; 2020. Chinese. [Google Scholar]
  • 16.Zhu DL. [The relationships between DNAH1, DNAH5, DNAH11 gene variations and asthenozoospermia] [thesis] Changchun: Jilin University; 2019. Chinese. [Google Scholar]
  • 17.Yang SM. [Morphological study and pathogenic genes iden in men with multiple morphological abnormalities of the sperm flagella] [thesis] Soochow: Soochow University; 2016. Chinese. [Google Scholar]
  • 18.Zhi HJ. [Study on the genetic diagnosis of two typical teratozoospermia] [thesis] Nanjing: Nanjing Normal University; 2019. Chinese. [Google Scholar]
  • 19.Oud MS, Houston BJ, Volozonoka L, Mastrorosa FK, Holt GS, Alobaidi BKS, et al. Exome sequencing reveals variants in known and novel candidate genes for severe sperm motility disorders. Hum Reprod. 2021;36:2597–2611. doi: 10.1093/humrep/deab099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wu H, Li W, He X, Liu C, Fang Y, Zhu F, et al. Novel CFAP43 and CFAP44 mutations cause male infertility with multiple morphological abnormalities of the sperm flagella (MMAF) Reprod Biomed Online. 2019;38:769–778. doi: 10.1016/j.rbmo.2018.12.037. [DOI] [PubMed] [Google Scholar]
  • 21.Fang YY. [Mutation Screening of Patients Who were Born from Related Parents with Multiple Morphological Abnormalities of the Sperm Flagella] [thesis] Hefei: Anhui Medical University; 2018. Chinese. [Google Scholar]
  • 22.Coutton C, Martinez G, Kherraf ZE, Amiri-Yekta A, Boguenet M, Saut A, et al. Bi-allelic mutations in ARMC2 lead to severe astheno-teratozoospermia due to sperm flagellum malformations in humans and mice. Am J Hum Genet. 2019;104:331–340. doi: 10.1016/j.ajhg.2018.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Coutton C, Vargas AS, Amiri-Yekta A, Kherraf ZE, Ben Mustapha SF, Le Tanno P, et al. Mutations in CFAP43 and CFAP44 cause male infertility and flagellum defects in Trypanosoma and human. Nat Commun. 2018;9:686. doi: 10.1038/s41467-017-02792-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tang S, Wang X, Li W, Yang X, Li Z, Liu W, et al. Biallelic mutations in CFAP43 and CFAP44 cause male infertility with multiple morphological abnormalities of the sperm flagella. Am J Hum Genet. 2017;100:854–864. doi: 10.1016/j.ajhg.2017.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wu H, Wang J, Cheng H, Gao Y, Liu W, Zhang Z, et al. Patients with severe asthenoteratospermia carrying SPAG6 or RSPH3 mutations have a positive pregnancy outcome following intracytoplasmic sperm injection. J Assist Reprod Genet. 2020;37:829–840. doi: 10.1007/s10815-020-01721-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wang JJ. [Identification of pathogenic genes and strategy of clinical treatment in male infertility patients with primary ciliary dyskinesia] [thesis] Hefei: Anhui Medical University; 2020. Chinese. [Google Scholar]
  • 27.Ma M, Stoyanova M, Rademacher G, Dutcher SK, Brown A, Zhang R. Structure of the decorated ciliary doublet microtubule. Cell. 2019;179:909–922.e12. doi: 10.1016/j.cell.2019.09.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Walton T, Wu H, Brown A. Structure of a microtubule-bound axonemal dynein. Nat Commun. 2021;12:477. doi: 10.1038/s41467-020-20735-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ishikawa T. Axoneme structure from motile cilia. Cold Spring Harb Perspect Biol. 2017;9:a028076. doi: 10.1101/cshperspect.a028076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Roberts AJ, Kon T, Knight PJ, Sutoh K, Burgess SA. Functions and mechanics of dynein motor proteins. Nat Rev Mol Cell Biol. 2013;14:713–726. doi: 10.1038/nrm3667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Firestone AJ, Weinger JS, Maldonado M, Barlan K, Langston LD, O’Donnell M, et al. Small-molecule inhibitors of the AAA+ ATPase motor cytoplasmic dynein. Nature. 2012;484:125–129. doi: 10.1038/nature10936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lin J, Okada K, Raytchev M, Smith MC, Nicastro D. Structural mechanism of the dynein power stroke. Nat Cell Biol. 2014;16:479–485. doi: 10.1038/ncb2939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.King SM. Axonemal dynein arms. Cold Spring Harb Perspect Biol. 2016;8:a028100. doi: 10.1101/cshperspect.a028100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Roberts AJ. Emerging mechanisms of dynein transport in the cytoplasm versus the cilium. Biochem Soc Trans. 2018;46:967–982. doi: 10.1042/BST20170568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pereira R, Sá R, Barros A, Sousa M. Major regulatory mechanisms involved in sperm motility. Asian J Androl. 2017;19:5–14. doi: 10.4103/1008-682X.167716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Nicastro D, McIntosh JR, Baumeister W. 3D structure of eukaryotic flagella in a quiescent state revealed by cryo-electron tomography. Proc Natl Acad Sci U S A. 2005;102:15889–15894. doi: 10.1073/pnas.0508274102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Bui KH, Sakakibara H, Movassagh T, Oiwa K, Ishikawa T. Molecular architecture of inner dynein arms in situ in Chlamydomonas reinhardtii flagella. J Cell Biol. 2008;183:923–932. doi: 10.1083/jcb.200808050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nicastro D, Schwartz C, Pierson J, Gaudette R, Porter ME, McIntosh JR. The molecular architecture of axonemes revealed by cryoelectron tomography. Science. 2006;313:944–948. doi: 10.1126/science.1128618. [DOI] [PubMed] [Google Scholar]
  • 39.Brokaw CJ, Kamiya R. Bending patterns of Chlamydomonas flagella: IV. Mutants with defects in inner and outer dynein arms indicate differences in dynein arm function. Cell Motil Cytoskeleton. 1987;8:68–75. doi: 10.1002/cm.970080110. [DOI] [PubMed] [Google Scholar]
  • 40.Maiti AK, Mattéi MG, Jorissen M, Volz A, Zeigler A, Bouvagnet P. Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes. Eur J Hum Genet. 2000;8:923–932. doi: 10.1038/sj.ejhg.5200555. [DOI] [PubMed] [Google Scholar]
  • 41.Vernon GG, Neesen J, Woolley DM. Further studies on knockout mice lacking a functional dynein heavy chain (MDHC7) 1 Evidence for a structural deficit in the axoneme. Cell Motil Cytoskeleton. 2005;61:65–73. doi: 10.1002/cm.20066. [DOI] [PubMed] [Google Scholar]
  • 42.Pennarun G, Escudier E, Chapelin C, Bridoux AM, Cacheux V, Roger G, et al. Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet. 1999;65:1508–1519. doi: 10.1086/302683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Guichard C, Harricane MC, Lafitte JJ, Godard P, Zaegel M, Tack V, et al. Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome) Am J Hum Genet. 2001;68:1030–1035. doi: 10.1086/319511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gadadhar S, Alvarez Viar G, Hansen JN, Gong A, Kostarev A, Ialy-Radio C, et al. Tubulin glycylation controls axonemal dynein activity, flagellar beat, and male fertility. Science. 2021;371:eabd4914. doi: 10.1126/science.abd4914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Aprea I, Raidt J, Höben IM, Loges NT, Nöthe-Menchen T, Pennekamp P, et al. Defects in the cytoplasmic assembly of axonemal dynein arms cause morphological abnormalities and dysmotility in sperm cells leading to male infertility. PLoS Genet. 2021;17:e1009306. doi: 10.1371/journal.pgen.1009306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Lucas JS, Davis SD, Omran H, Shoemark A. Primary ciliary dyskinesia in the genomics age. Lancet Respir Med. 2020;8:202–216. doi: 10.1016/S2213-2600(19)30374-1. [DOI] [PubMed] [Google Scholar]
  • 47.Kuehni CE, Frischer T, Strippoli MP, Maurer E, Bush A, Nielsen KG, et al. ERS Task Force on Primary Ciliary Dyskinesia in Children. Factors influencing age at diagnosis of primary ciliary dyskinesia in European children. Eur Respir J. 2010;36:1248–1258. doi: 10.1183/09031936.00001010. [DOI] [PubMed] [Google Scholar]
  • 48.O’Callaghan C, Chetcuti P, Moya E. High prevalence of primary ciliary dyskinesia in a British Asian population. Arch Dis Child. 2010;95:51–52. doi: 10.1136/adc.2009.158493. [DOI] [PubMed] [Google Scholar]
  • 49.Butterfield R. Primary ciliary dyskinesia. Pediatr Rev. 2017;38:145–146. doi: 10.1542/pir.2016-0108. [DOI] [PubMed] [Google Scholar]
  • 50.Coutton C, Escoffier J, Martinez G, Arnoult C, Ray PF. Teratozoospermia: spotlight on the main genetic actors in the human. Hum Reprod Update. 2015;21:455–485. doi: 10.1093/humupd/dmv020. [DOI] [PubMed] [Google Scholar]
  • 51.O’Callaghan C, Rutman A, Williams GM, Hirst RA. Inner dynein arm defects causing primary ciliary dyskinesia: repeat testing required. Eur Respir J. 2011;38:603–607. doi: 10.1183/09031936.00108410. [DOI] [PubMed] [Google Scholar]
  • 52.Imtiaz F, Allam R, Ramzan K, Al-Sayed M. Variation in DNAH1 may contribute to primary ciliary dyskinesia. BMC Med Genet. 2015;16:14. doi: 10.1186/s12881-015-0162-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yue Y, Huang Q, Zhu P, Zhao P, Tan X, Liu S, et al. Identification of pathogenic mutations and investigation of the NOTCH pathway activation in Kartagener syndrome. Front Genet. 2019;10:749. doi: 10.3389/fgene.2019.00749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Emiralioğlu N, Taşkıran EZ, Koşukcu C, Bilgiç E, Atilla P, Kaya B, et al. Genotype and phenotype evaluation of patients with primary ciliary dyskinesia: first results from Turkey. Pediatr Pulmonol. 2020;55:383–393. doi: 10.1002/ppul.24583. [DOI] [PubMed] [Google Scholar]
  • 55.Neesen J, Kirschner R, Ochs M, Schmiedl A, Habermann B, Mueller C, et al. Disruption of an inner arm dynein heavy chain gene results in asthenozoospermia and reduced ciliary beat frequency. Hum Mol Genet. 2001;10:1117–1128. doi: 10.1093/hmg/10.11.1117. [DOI] [PubMed] [Google Scholar]
  • 56.Woolley DM, Neesen J, Vernon GG. Further studies on knockout mice lacking a functional dynein heavy chain (MDHC7) 2 A developmental explanation for the asthenozoospermia. Cell Motil Cytoskeleton. 2005;61:74–82. doi: 10.1002/cm.20067. [DOI] [PubMed] [Google Scholar]
  • 57.Salonia A, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioğlu A, et al. Sexual and reproductive health [Internet] Arnhem: European Association of Urology; c2021. [cited 2021 Mon date]. Available from: https://uroweb.org/guideline/sexual-and-reproductive-health/#10 . [Google Scholar]
  • 58.Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA. WHO manual for the standardized investigation, diagnosis and management of the infertile male. Cambridge: Cambridge University Press; 2000. p. 1. [Google Scholar]
  • 59.Wahlberg A. The birth and routinization of IVF in China. Reprod Biomed Soc Online. 2016;2:97–107. doi: 10.1016/j.rbms.2016.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.O’Neill CL, Chow S, Rosenwaks Z, Palermo GD. Development of ICSI. Reproduction. 2018;156:F51–F58. doi: 10.1530/REP-18-0011. [DOI] [PubMed] [Google Scholar]
  • 61.Fauque P, Albert M, Serres C, Viallon V, Davy C, Epelboin S, et al. From ultrastructural flagellar sperm defects to the health of babies conceived by ICSI. Reprod Biomed Online. 2009;19:326–336. doi: 10.1016/s1472-6483(10)60166-6. [DOI] [PubMed] [Google Scholar]
  • 62.Mitchell V, Rives N, Albert M, Peers MC, Selva J, Clavier B, et al. Outcome of ICSI with ejaculated spermatozoa in a series of men with distinct ultrastructural flagellar abnormalities. Hum Reprod. 2006;21:2065–2074. doi: 10.1093/humrep/del130. [DOI] [PubMed] [Google Scholar]
  • 63.Chen J, Yuan HJ, Cui YQ, Yan W, Lian HY, Liu XY, et al. [Impact of multiple morphological anomalies of the flagella on the outcomes of intracytoplasmic sperm injection for males with infertility] Zhonghua Yi Xue Za Zhi. 2018;98:2914–2919. doi: 10.3760/cma.j.issn.0376-2491.2018.36.008. Chinese. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement File 1
wjmh-40-551-s001.pdf (132.3KB, pdf)
Supplement File 2
wjmh-40-551-s002.xls (27.9KB, xls)
Supplement File 3
wjmh-40-551-s003.xls (11.3KB, xls)

Articles from The World Journal of Men's Health are provided here courtesy of Korean Society for Sexual Medicine and Andrology

RESOURCES